Skip to content

Kodiak Sciences

US · KOD #1934 by market cap Listed 2018
97.17 -0.73 -0.75%
Periodic snapshot; not a real-time feed. · 2026-11-20 19:57

Price chart

Pre-market 97.07 -0.85%
After-hours 97.26 +0.09%
Overnight 97.90 0.00%
111.1929.6197.172026-05-262026-11-20
MA5MA10MA20MA60
— MA5 — MA10 — MA20 — MA60
Reader sentiment Are you bullish or bearish on KOD?

Anonymous reader poll. Unscientific, not investment advice.

✦ StockVane Quant Insights how this is computed

Quant Sentiment Bullish
  • Recent price momentum is +270.0% on average (3-month/1-year).
  • Main-fund capital flow has been a net inflow over the last 45 sessions.
  • Short interest has fallen to 12.9% of float.
  • Analyst tilt is Buy.
Quant Technical Outlook Neutral
  • Price is below its 20-day average and above its 60-day average.
  • The 20-day average is above the 60-day average, a short-term uptrend.
Quant Rating, last 30 days A → A

Computed by a StockVane algorithm from historical price, valuation and analyst data - not a person, not a forecast guarantee, and not investment advice.

Factor grades

Ranked against 2848 U.S. stocks StockVane covers.

Last computed: 2026-11-21 20:27 UTC

Data coverage: 4 of 6 factors. Missing data is not a zero score.

Overall B-

The radar needs all six factors. Available grades are shown below.

Valuation N/A

How expensive the stock is versus earnings, sales and its own 5-year history.

Not enough data to grade this factor.

Growth N/A

How fast revenue, profit and free cash flow are compounding.

Not enough data to grade this factor.

Profitability F

How much profit the business keeps from each dollar of sales and capital.

Return on equity -149.5% Better than 4%
Return on invested capital -107.3% Better than 2%
Momentum A+

Recent price strength, skipping the latest month to avoid short-term noise.

3-month return 153.5% Better than 100%
6-month return 168.2% Better than 100%
12-month return (ex latest month) 313.0% Better than 100%
Distance below 52-week high 13.8% Better than 75%
Financial Health C+

Balance-sheet strength: leverage, liquidity and interest coverage.

Current ratio 4.7x Better than 85%
Debt to assets 16.8% Better than 60%
Interest coverage -20,036.8x Better than 0%
Analyst View B

What the Street thinks: share of Buy ratings and upside to the average target.

Analysts rating Buy 85.7% Better than 67%
Upside to average target 30.9% Better than 50%

Grades are relative rankings, not forecasts: A+ is the top 5% of the covered stocks on a factor, F the bottom 3%. Valuation is not adjusted for sector. Background recomputation is scheduled every 6 hours; actual computation time is shown above, and source datasets have different reporting dates. Not investment advice or tailored to your financial situation.

Performance

1W -12.61%
1M +4.52%
3M +143.90%
6M +168.28%
YTD +247.53%
1Y +396.02%
3Y +3,898.77%
5Y -1.51%

Key statistics

Price & volume

Prev close
97.90
Open
97.00
Day range
96.53 - 100.89
Avg price
97.70
Volume
693.12K
Turnover
67.72M
Amplitude
4.46%
52-week range
20.38 - 112.79

Valuation

P/E
-22.49
P/E (TTM)
-23.82
P/B
506.09
EPS
-4.32
Net profit
-282.51M
Net assets
12.56M

Share structure

Market cap
6.35B
Float cap
3.82B
Shares out
65.40M
Float shares
39.27M

Dividend & listing

Dividend (TTM)
0.00
Listing date
2018-10-04
52-week range 83% of range
20.38 112.79

13.8% below the 52-week high

Trading activity

Net capital flow main funds, last 45 sessions

+44.60M net over the window

Short interest

Shares short
8.12M
As of
2026-10-30

Frequently asked questions

What is the current stock price of Kodiak Sciences (KOD)?

Kodiak Sciences last traded at 97.17. This page shows a periodic quote snapshot. Check the displayed quote time.

What is Kodiak Sciences's market cap?

About 6.35B.

What is the P/E ratio of Kodiak Sciences?

The trailing twelve-month P/E is -23.82. The Valuation tab shows it against the stock's own five-year range.

Does Kodiak Sciences pay a dividend?

Kodiak Sciences does not currently pay a regular dividend.

Is Kodiak Sciences a buy according to analysts?

The consensus of 7 analysts is a Buy rating, with an average 12-month price target of 127.20, which implies 30.9% upside from the current price. This is not investment advice.

What is Kodiak Sciences's StockVane Quant Rating?

The StockVane Momentum strategy currently rates Kodiak Sciences a C (Hold). Mid-pack momentum — held if you own it, not a fresh buy. Not investment advice.

Quote time 2026-11-20 19:57:11 · For reference only, not investment advice and not tailored to your situation.

Kodiak Sciences discussion 0 comments

Add a comment